Pell BMT

Founded in 2017, PELL Bio-Med Technology Co., Ltd. is a Taiwan-based biotechnology company specializing in cell culture technology and cell therapy applications. Led by Professor Steve C.L. Lin, a globally renowned immunologist and Fellow of the Royal College of Surgeons (FRCS), PELL is committed to advancing healthcare through innovation. With roots in groundbreaking research at the University of Oxford, Professor Lin brings over two decades of expertise in cancer immunotherapy and stem cell therapy to the company. Headquartered in Neihu Science Park, Taipei, with a branch office in Kaohsiung, PELL collaborates with leading research institutions worldwide. Guided by the values of health, care, precision, and professionalism, PELL is dedicated to pioneering advancements in cell therapy and regenerative medicine.